The Future of Myeloma Care is here: remarkable results from all antibody combination
Groundbreaking data from the 2025 ASH meeting reveals a transformative approach to multiple myeloma care. The TecLILLE study, using a chemotherapy-free, steroid-free antibody combination, achieved a 100% response rate and deep remissions in transplant-ineligible patients, offering a gentler yet highly effective treatment paradigm.
A concise list of helpful resources for cancer patients
For cancer patients in the U.S., various resources offer crucial support. These organizations provide vital information, practical assistance, and emotional guidance. This guide details key resources to help patients and families.
The Transformative Promise of CAR-T Cell Therapy in Cancer Treatment
CAR-T cell therapy is a groundbreaking oncology treatment, utilizing the patient's immune system to target and destroy cancer cells. This innovative approach offers significant hope and new life-saving options for patients.
Advances in Breast Cancer Screening
Breast cancer screening is a vital tool for early detection and effective management, significantly improving patient outcomes. This article explores the rationale for screening, identifies risk groups, details various screening modalities, and highlights the transformative role of AI and future advancements in detection. The goal is to enhance early detection, improve diagnostic accuracy, and usher in an era of personalized patient care.
EV302: A New Approach to the Treatment of Bladder Cancer
The EV302 clinical trial presents a groundbreaking dual therapy for advanced urothelial cancer, combining enfortumab vedotin and pembrolizumab. This new approach has nearly doubled patient life expectancy and progression-free survival compared to traditional chemotherapy, offering a significant paradigm shift in bladder cancer treatment. The findings signify a new era of hope for patients, with regulatory approval processes underway to make this innovative therapy widely accessible.
Breakthrough in Bladder Cancer: How EV302 drugs work
The EV302 trial, presented at ESMO 2023, represents a significant advancement in bladder cancer treatment. This article details the dual mechanism of action of enfortumab vedotin and pembrolizumab, highlighting their synergistic effect and potential side effects. It aims to provide crucial insights into this pivotal trial and its implications for future care.
The Healing Power of Social Support During Cancer Treatment.
Navigating cancer treatment is a profound challenge. This article highlights how a robust social support system, including friends, family, and support groups, is crucial for patients' emotional well-being and resilience, complementing medical care effectively.
Evidence-Based Cancer Care
Complete Remission is dedicated to spreading evidence-based information about cancer prevention and treatment. Our mission is to provide collaborative, integrative, personalized, and patient-centered cancer care information that empowers patients and families on their journey.